Preparing for the Waiting Period in the Pharmacy Following COVID-19 Vaccinations
December 23rd 2020Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for managing the waiting period in the pharmacy following COVID-19 immunizations.
Communication Is Critical for Effective COVID-19 Immunization in a Hospital Pharmacy
December 23rd 2020Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for immunizing staff at a hospital pharmacy with the COVID-19 vaccines.
Preparatory Actions Pharmacies Should Take to Prepare to Immunize the Public Against COVID-19
December 22nd 2020Pharmacy Times® interviewed Michael Flannery, PharmD, of the University of Rochester Medical Center, on the process that the hospital pharmacy has developed for vaccinations following the arrival of the Pfizer and Moderna COVID-19 vaccines.
Recent Drop in Children's Immunizations May Result in the Rise of Certain Highly Contagious Diseases
December 22nd 2020Pharmacy Times® interviewed Jason Kay, PharmD, MS, the director of pharmacy programs at of Blue Cross Blue Shield Association, on how the recent drop in immunizations among children may result in the rise of certain highly contagious diseases.
Managing Concerns Around Vaccinating the Public With the COVID-19 Vaccines
December 22nd 2020Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the concerns he has regarding the COVID-19 vaccination process ahead.
The Work of the COVID-19 Vaccine Education and Equity Project to Support COVID-19 Immunization
December 19th 2020Pharmacy Times® interviewed Sue Peschin, president and CEO of Alliance for Aging Research, on the work that the COVID-19 Vaccine Education and Equity Project is doing to engage diverse constituencies on the importance of the clinical trials process, regulatory review, and equitable access to COVID-19 vaccines.
The Importance of Ensuring Equitable Access and Education on COVID-19 Vaccines
December 18th 2020Pharmacy Times® interviewed Sue Peschin, president and CEO of Alliance for Aging Research, on the work that the COVID-19 Vaccine Education and Equity Project is doing to support education about and equitable access to COVID-19 vaccines.
How Pharmacies Can Facilitate the Second Dose Administration of the COVID-19 Vaccines
December 17th 2020Pharmacy Times® interviewed John Beckner, the senior director of strategic initiatives at the National Community Pharmacists Association, on how pharmacists can help people come back for the second dose of the COVID-19 vaccine.
Managing the Challenges Pharmacies May Face When Receiving and Administering COVID-19 Vaccines
December 17th 2020Pharmacy Times® interviewed John Beckner, the senior director of strategic initiatives at the National Community Pharmacists Association, on some of the challenges community pharmacies may need to manage when receiving and administering COVID-19 vaccines.
How Community Pharmacies Can Prepare for the Arrival of COVID-19 Vaccines
December 17th 2020Pharmacy Times® interviewed John Beckner, the senior director of strategic initiatives at the National Community Pharmacists Association, on the work needed to prepare for the arrival and administration of COVID-19 vaccines.
Partnership Will Support Collaboration on Health Science Research During COVID-19
December 15th 2020Pharmacy Times® interviewed Signe Pringle, the assistant secretary for the Maryland Department of Commerce, on a signed partnership between Quebec and Maryland to foster collaboration around health science research during COVID-19 and beyond.
Making Treatment Decisions for Patients with Myelofibrosis
December 10th 2020Rami Komrokji, MD, clinical director of malignant hematology and department lead clinical investigator at the H. Lee Moffitt Cancer Center and Research Institute speaks about factors in treatment decisions for patients with myelofibrosis.
The Most Interesting Results from the RESET Clinical Trial
December 9th 2020In an interview with Pharmacy Times, Helen Thackray, MD, reveals what finding she believes was the most interesting after analyzing the results of the RESET clinical trial, which covers the early initiation with rivipansel for acute vaso-occulusive crisis in sickle cell disease.
Future Treatment Options for Patients With Relapsed/Refractory Multiple Myeloma
December 9th 2020Suzanne Trudel, MD, MSC, FRCPC, of the University of Toronto and the Princess Margaret Cancer Centre in Toronto, discusses closing thoughts on the results of the study and its implications for future treatment options for patients with relapsed/refractory multiple myeloma.
Future Plans for the Evaluation of Ponatinib During the Ongoing OPTIC Trial
December 9th 2020Hagop Kantarjian, MD, of the University of Texas MD Anderson Cancer Center, discusses what his team’s plans are for the evaluation of ponatinib during the remaining portion of the OPTIC trial, which is currently ongoing.